Infectious Diseases in Cancer Patients: An Overview

The predisposition of cancer patients to infectious diseases which contribute to the gravity of their prognosis is well documented. The current success in therapy of both malignancies and infections is unprecedented. However, the overall co-morbidity of these conditions is still a major problem in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zorina, Tatiana, Styche, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123467/
http://dx.doi.org/10.1007/978-3-319-20669-1_14
_version_ 1783515643414315008
author Zorina, Tatiana
Styche, Alexis
author_facet Zorina, Tatiana
Styche, Alexis
author_sort Zorina, Tatiana
collection PubMed
description The predisposition of cancer patients to infectious diseases which contribute to the gravity of their prognosis is well documented. The current success in therapy of both malignancies and infections is unprecedented. However, the overall co-morbidity of these conditions is still a major problem in management of these patients. Paradoxically, to some degree the problem of containing infectious complications is directly associated with the vigor of the anti-cancer therapeutic regimens. The objective of this chapter is to provide an up to date overview of our understanding of the infectious complications in cancer patients based on the type of infection and immune responses.
format Online
Article
Text
id pubmed-7123467
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-71234672020-04-06 Infectious Diseases in Cancer Patients: An Overview Zorina, Tatiana Styche, Alexis Infection and Cancer: Bi-Directorial Interactions Article The predisposition of cancer patients to infectious diseases which contribute to the gravity of their prognosis is well documented. The current success in therapy of both malignancies and infections is unprecedented. However, the overall co-morbidity of these conditions is still a major problem in management of these patients. Paradoxically, to some degree the problem of containing infectious complications is directly associated with the vigor of the anti-cancer therapeutic regimens. The objective of this chapter is to provide an up to date overview of our understanding of the infectious complications in cancer patients based on the type of infection and immune responses. 2015-06-13 /pmc/articles/PMC7123467/ http://dx.doi.org/10.1007/978-3-319-20669-1_14 Text en © Springer International Publishing Switzerland 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zorina, Tatiana
Styche, Alexis
Infectious Diseases in Cancer Patients: An Overview
title Infectious Diseases in Cancer Patients: An Overview
title_full Infectious Diseases in Cancer Patients: An Overview
title_fullStr Infectious Diseases in Cancer Patients: An Overview
title_full_unstemmed Infectious Diseases in Cancer Patients: An Overview
title_short Infectious Diseases in Cancer Patients: An Overview
title_sort infectious diseases in cancer patients: an overview
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123467/
http://dx.doi.org/10.1007/978-3-319-20669-1_14
work_keys_str_mv AT zorinatatiana infectiousdiseasesincancerpatientsanoverview
AT stychealexis infectiousdiseasesincancerpatientsanoverview

Ejemplares similares